Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 韦妙宜教授 (那打素护理学院) |
全文
| 数位物件识别号 (DOI) http://dx.doi.org/10.3390/ph3103343 |
引用次数
Scopushttp://aims.cuhk.edu.hk/converis/portal/Publication/9Scopus source URL
其它资讯
摘要There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A-F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. ? 2010 by the authors.
着者Waye M.M.Y., Sing C.W.
期刊名称Pharmaceuticals
详细描述To ORKTS: DOI: 10.33http://aims.cuhk.edu.hk/converis/portal/Publication/90/ph3103343
出版年份2010
月份12
日期20
卷号3
期次10
出版社Multidisciplinary Digital Publishing Institute (MDPI)
出版地Switzerland
页次3343 - 3354
国际标準期刊号1424-8247
语言英式英语
关键词Adenovirus, microRNA, Pharmaceuticals
